A case of possible atypical demyelinating event of the central nervous system following COVID-19

•Clinical awareness of physicians about neurological complications of COVID-19 decreases the mortality rate among infected people.•Neurological presentation of COVID-19 infection categorized into two groups of symptoms of the central nervous system (CNS) and of the peripheral nervous system (PNS).•C...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Multiple sclerosis and related disorders Ročník 44; s. 102324
Hlavní autoři: Zoghi, Anahita, Ramezani, Mahtab, Roozbeh, Mehrdad, Darazam, Ilad Alavi, Sahraian, Mohammad Ali
Médium: Journal Article
Jazyk:angličtina
Vydáno: Netherlands Elsevier B.V 01.09.2020
Témata:
ISSN:2211-0348, 2211-0356, 2211-0356
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract •Clinical awareness of physicians about neurological complications of COVID-19 decreases the mortality rate among infected people.•Neurological presentation of COVID-19 infection categorized into two groups of symptoms of the central nervous system (CNS) and of the peripheral nervous system (PNS).•Cytokine storm, a well-known immune reaction to this specific viral infection, can cause inflammation and central nervous system (CNS) tissue axonal or demyelinating damage.•Our patient had a central demyelinating brain injury following COVID-19 infection. After the novel coronavirus disease outbreak first began in Wuhan, China, in December 2019, the viral epidemic has quickly spread across the world, and it is now a major public health concern. Here we present a 21-year-old male with encephalomyelitis following intermittent vomiting and malaise for 4 days. He reported upper respiratory signs and symptoms 2 weeks before this presentation. Two cerebrospinal fluid (CSF) analyses were notable for mononuclear pleocytosis, elevated protein (more than 100 mg/dl), and hypoglycorrhachia. Brain Magnetic Resonance Imaging (MRI) showed bilateral posterior internal capsule lesions extending to the ventral portion of the pons and a marbled splenium hyperintensity pattern. Cervical and thoracic MRI showed longitudinally extensive transverse myelitis (LETM), none of which were enhanced with gadolinium. Both the AQP4 and MOG antibodies were negative. Spiral chest computed tomography (CT) scan confirmed to COVID-19 as did the high IgG level against coronavirus, but the oropharyngeal swabs were negative. Neurological manifestations of COVID-19 have not been adequately studied. Some COVID-19 patients, especially those suffering from a severe disease, are highly likely to have central nervous system (CNS) manifestations. Our case is a post-COVID-19 demyelinating event in the CNS.
AbstractList •Clinical awareness of physicians about neurological complications of COVID-19 decreases the mortality rate among infected people.•Neurological presentation of COVID-19 infection categorized into two groups of symptoms of the central nervous system (CNS) and of the peripheral nervous system (PNS).•Cytokine storm, a well-known immune reaction to this specific viral infection, can cause inflammation and central nervous system (CNS) tissue axonal or demyelinating damage.•Our patient had a central demyelinating brain injury following COVID-19 infection. After the novel coronavirus disease outbreak first began in Wuhan, China, in December 2019, the viral epidemic has quickly spread across the world, and it is now a major public health concern. Here we present a 21-year-old male with encephalomyelitis following intermittent vomiting and malaise for 4 days. He reported upper respiratory signs and symptoms 2 weeks before this presentation. Two cerebrospinal fluid (CSF) analyses were notable for mononuclear pleocytosis, elevated protein (more than 100 mg/dl), and hypoglycorrhachia. Brain Magnetic Resonance Imaging (MRI) showed bilateral posterior internal capsule lesions extending to the ventral portion of the pons and a marbled splenium hyperintensity pattern. Cervical and thoracic MRI showed longitudinally extensive transverse myelitis (LETM), none of which were enhanced with gadolinium. Both the AQP4 and MOG antibodies were negative. Spiral chest computed tomography (CT) scan confirmed to COVID-19 as did the high IgG level against coronavirus, but the oropharyngeal swabs were negative. Neurological manifestations of COVID-19 have not been adequately studied. Some COVID-19 patients, especially those suffering from a severe disease, are highly likely to have central nervous system (CNS) manifestations. Our case is a post-COVID-19 demyelinating event in the CNS.
Highlights•Clinical awareness of physicians about neurological complications of COVID-19 decreases the mortality rate among infected people. •Neurological presentation of COVID-19 infection categorized into two groups of symptoms of the central nervous system (CNS) and of the peripheral nervous system (PNS). •Cytokine storm, a well-known immune reaction to this specific viral infection, can cause inflammation and central nervous system (CNS) tissue axonal or demyelinating damage. •Our patient had a central demyelinating brain injury following COVID-19 infection.
After the novel coronavirus disease outbreak first began in Wuhan, China, in December 2019, the viral epidemic has quickly spread across the world, and it is now a major public health concern. Here we present a 21-year-old male with encephalomyelitis following intermittent vomiting and malaise for 4 days. He reported upper respiratory signs and symptoms 2 weeks before this presentation. Two cerebrospinal fluid (CSF) analyses were notable for mononuclear pleocytosis, elevated protein (more than 100 mg/dl), and hypoglycorrhachia. Brain Magnetic Resonance Imaging (MRI) showed bilateral posterior internal capsule lesions extending to the ventral portion of the pons and a marbled splenium hyperintensity pattern. Cervical and thoracic MRI showed longitudinally extensive transverse myelitis (LETM), none of which were enhanced with gadolinium. Both the AQP4 and MOG antibodies were negative. Spiral chest computed tomography (CT) scan confirmed to COVID-19 as did the high IgG level against coronavirus, but the oropharyngeal swabs were negative. Neurological manifestations of COVID-19 have not been adequately studied. Some COVID-19 patients, especially those suffering from a severe disease, are highly likely to have central nervous system (CNS) manifestations. Our case is a post-COVID-19 demyelinating event in the CNS.After the novel coronavirus disease outbreak first began in Wuhan, China, in December 2019, the viral epidemic has quickly spread across the world, and it is now a major public health concern. Here we present a 21-year-old male with encephalomyelitis following intermittent vomiting and malaise for 4 days. He reported upper respiratory signs and symptoms 2 weeks before this presentation. Two cerebrospinal fluid (CSF) analyses were notable for mononuclear pleocytosis, elevated protein (more than 100 mg/dl), and hypoglycorrhachia. Brain Magnetic Resonance Imaging (MRI) showed bilateral posterior internal capsule lesions extending to the ventral portion of the pons and a marbled splenium hyperintensity pattern. Cervical and thoracic MRI showed longitudinally extensive transverse myelitis (LETM), none of which were enhanced with gadolinium. Both the AQP4 and MOG antibodies were negative. Spiral chest computed tomography (CT) scan confirmed to COVID-19 as did the high IgG level against coronavirus, but the oropharyngeal swabs were negative. Neurological manifestations of COVID-19 have not been adequately studied. Some COVID-19 patients, especially those suffering from a severe disease, are highly likely to have central nervous system (CNS) manifestations. Our case is a post-COVID-19 demyelinating event in the CNS.
After the novel coronavirus disease outbreak first began in Wuhan, China, in December 2019, the viral epidemic has quickly spread across the world, and it is now a major public health concern. Here we present a 21-year-old male with encephalomyelitis following intermittent vomiting and malaise for 4 days. He reported upper respiratory signs and symptoms 2 weeks before this presentation. Two cerebrospinal fluid (CSF) analyses were notable for mononuclear pleocytosis, elevated protein (more than 100 mg/dl), and hypoglycorrhachia. Brain Magnetic Resonance Imaging (MRI) showed bilateral posterior internal capsule lesions extending to the ventral portion of the pons and a marbled splenium hyperintensity pattern. Cervical and thoracic MRI showed longitudinally extensive transverse myelitis (LETM), none of which were enhanced with gadolinium. Both the AQP4 and MOG antibodies were negative. Spiral chest computed tomography (CT) scan confirmed to COVID-19 as did the high IgG level against coronavirus, but the oropharyngeal swabs were negative. Neurological manifestations of COVID-19 have not been adequately studied. Some COVID-19 patients, especially those suffering from a severe disease, are highly likely to have central nervous system (CNS) manifestations. Our case is a post-COVID-19 demyelinating event in the CNS.
• Clinical awareness of physicians about neurological complications of COVID-19 decreases the mortality rate among infected people. • Neurological presentation of COVID-19 infection categorized into two groups of symptoms of the central nervous system (CNS) and of the peripheral nervous system (PNS). • Cytokine storm, a well-known immune reaction to this specific viral infection, can cause inflammation and central nervous system (CNS) tissue axonal or demyelinating damage. • Our patient had a central demyelinating brain injury following COVID-19 infection. After the novel coronavirus disease outbreak first began in Wuhan, China, in December 2019, the viral epidemic has quickly spread across the world, and it is now a major public health concern. Here we present a 21-year-old male with encephalomyelitis following intermittent vomiting and malaise for 4 days. He reported upper respiratory signs and symptoms 2 weeks before this presentation. Two cerebrospinal fluid (CSF) analyses were notable for mononuclear pleocytosis, elevated protein (more than 100 mg/dl), and hypoglycorrhachia. Brain Magnetic Resonance Imaging (MRI) showed bilateral posterior internal capsule lesions extending to the ventral portion of the pons and a marbled splenium hyperintensity pattern. Cervical and thoracic MRI showed longitudinally extensive transverse myelitis (LETM), none of which were enhanced with gadolinium. Both the AQP4 and MOG antibodies were negative. Spiral chest computed tomography (CT) scan confirmed to COVID-19 as did the high IgG level against coronavirus, but the oropharyngeal swabs were negative. Neurological manifestations of COVID-19 have not been adequately studied. Some COVID-19 patients, especially those suffering from a severe disease, are highly likely to have central nervous system (CNS) manifestations. Our case is a post-COVID-19 demyelinating event in the CNS.
ArticleNumber 102324
Author Darazam, Ilad Alavi
Ramezani, Mahtab
Sahraian, Mohammad Ali
Roozbeh, Mehrdad
Zoghi, Anahita
Author_xml – sequence: 1
  givenname: Anahita
  surname: Zoghi
  fullname: Zoghi, Anahita
  organization: Assistant professor of Neurology, Skull Base research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 2
  givenname: Mahtab
  orcidid: 0000-0002-1148-3998
  surname: Ramezani
  fullname: Ramezani, Mahtab
  email: drramezani23@gmail.com
  organization: Assistant professor of Neurology, Skull Base research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 3
  givenname: Mehrdad
  surname: Roozbeh
  fullname: Roozbeh, Mehrdad
  organization: Resident of Neurology, Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 4
  givenname: Ilad Alavi
  surname: Darazam
  fullname: Darazam, Ilad Alavi
  organization: Assistant professor of Infectious disease, Infectious Diseases and Tropical Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 5
  givenname: Mohammad Ali
  orcidid: 0000-0002-3224-8807
  surname: Sahraian
  fullname: Sahraian, Mohammad Ali
  organization: Professor of Neurology, Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32615528$$D View this record in MEDLINE/PubMed
BookMark eNqFUstu1DAUtVARLaVfgISyZJPBj9hJhKhUDa9KlbrgsTWOc916SOzBzgzK32MzwwgqofHGln3Oudfn3KfoxHkHCD0neEEwEa9WizGq0C8opvmGMlo9QmeUElJixsXJ4Vw1p-gixhVOS3BSCfIEnTIqCOe0OUPfrgqtIhTeFGsfo-0GKNQ0r61WQ9HDOMNgnZqsuytgC27KwOkeCp3OIUEchK3fxCLOcYKxMH4Y_M-MXt5-vX5bkvYZemzUEOFiv5-jL-_ffV5-LG9uP1wvr25KLRidSo6rzjDT4F7xWjFTVz0zFVVENaCBcNCmrlvBulq0XFVdQw0WuudAVFdzJtg5utzprjfdCP2-P7kOdlRhll5Z-e-Ls_fyzm9lzQhpCU8CL_cCwf_YQJzkaKOGYVAO0g8lrSgmjHPcJuiLv2sdivyxNQHYDqBDMjWAOUAIljk_uZK_85M5P7nLL7HaByxtp-S9zw3b4Qj3zY4LyeOthSCjtuA09DaAnmTv7RH-5QO-TsHnKfgOM8SV3wSX4pNERiqx_JSnKw8XxQxXGGeB1_8XOFr-F3SU4Cs
CitedBy_id crossref_primary_10_2169_internalmedicine_5986_25
crossref_primary_10_1080_00207454_2022_2098731
crossref_primary_10_3389_fneur_2022_887164
crossref_primary_10_1515_revneuro_2021_0148
crossref_primary_10_3389_fmed_2021_629828
crossref_primary_10_1098_rsob_240138
crossref_primary_10_1002_alz_12255
crossref_primary_10_1007_s13365_021_00986_w
crossref_primary_10_1155_2020_6682251
crossref_primary_10_1016_j_jns_2021_117316
crossref_primary_10_1016_j_hrthm_2022_07_014
crossref_primary_10_1007_s12024_021_00440_7
crossref_primary_10_4103_0028_3886_370449
crossref_primary_10_1186_s13027_023_00485_z
crossref_primary_10_1007_s13760_021_01691_5
crossref_primary_10_1016_j_nerep_2022_100102
crossref_primary_10_1016_j_humgen_2025_201430
crossref_primary_10_1097_PHM_0000000000001857
crossref_primary_10_1111_jon_12880
crossref_primary_10_1016_j_jneuroim_2022_577939
crossref_primary_10_1016_j_jocn_2020_07_074
crossref_primary_10_3390_s22166312
crossref_primary_10_3390_metabo12100912
crossref_primary_10_1016_j_clineuro_2021_106513
crossref_primary_10_1007_s00415_021_10771_8
crossref_primary_10_1016_j_jns_2020_117085
crossref_primary_10_1002_jcla_24426
crossref_primary_10_1007_s00415_021_10947_2
crossref_primary_10_1080_10790268_2021_1888022
crossref_primary_10_1016_j_nerep_2022_100063
crossref_primary_10_3389_fimmu_2021_755333
crossref_primary_10_3389_fneur_2021_820049
crossref_primary_10_4103_0028_3886_329572
crossref_primary_10_1016_j_jns_2022_120463
crossref_primary_10_1080_00207454_2021_1973000
crossref_primary_10_12998_wjcc_v12_i21_4827
crossref_primary_10_1186_s12883_021_02152_5
crossref_primary_10_3390_ijerph17186688
crossref_primary_10_3389_fphys_2020_622466
crossref_primary_10_1212_WNL_0000000000209188
crossref_primary_10_3390_brainsci11101354
crossref_primary_10_3390_ijms231911291
crossref_primary_10_1055_s_0043_1767713
crossref_primary_10_1177_11795735231167869
crossref_primary_10_1002_acn3_51609
crossref_primary_10_3389_fimmu_2021_653786
crossref_primary_10_1089_vim_2023_0116
crossref_primary_10_3390_brainsci12030367
crossref_primary_10_1097_YCO_0000000000000688
crossref_primary_10_1007_s00415_021_10611_9
crossref_primary_10_1089_neu_2020_7332
crossref_primary_10_3390_vaccines11071225
crossref_primary_10_1080_01616412_2021_1915078
crossref_primary_10_1007_s13365_021_00945_5
crossref_primary_10_3389_fcimb_2022_815738
crossref_primary_10_1016_j_msard_2021_102900
crossref_primary_10_1007_s12035_021_02383_0
crossref_primary_10_1136_bcr_2022_250535
crossref_primary_10_1515_revneuro_2021_0082
crossref_primary_10_1016_j_msard_2020_102723
crossref_primary_10_3389_fmed_2020_594495
crossref_primary_10_1212_CPJ_0000000000001175
crossref_primary_10_1186_s42466_022_00191_y
crossref_primary_10_3389_fimmu_2022_871276
crossref_primary_10_1111_jon_12819
crossref_primary_10_1007_s13337_022_00793_9
crossref_primary_10_2174_0929867328666210506161543
crossref_primary_10_1007_s00415_021_10752_x
Cites_doi 10.5812/ijp.102569
10.1016/j.jns.2020.116832
10.1016/j.bbi.2020.04.017
10.1056/NEJMc2009191
10.3390/jcm8010003
10.1016/S1474-4422(20)30109-5
10.1016/j.bbi.2020.05.002
10.1212/WNL.0000000000001729
10.3988/jcn.2017.13.3.227
10.3390/v12010014
10.1016/j.jneuroim.2017.01.003
10.1148/radiol.2020201187
10.1038/ni.3656
10.3389/fncel.2018.00386
ContentType Journal Article
Copyright 2020 Elsevier B.V.
Elsevier B.V.
Copyright © 2020 Elsevier B.V. All rights reserved.
2020 Elsevier B.V. All rights reserved. 2020 Elsevier B.V.
Copyright_xml – notice: 2020 Elsevier B.V.
– notice: Elsevier B.V.
– notice: Copyright © 2020 Elsevier B.V. All rights reserved.
– notice: 2020 Elsevier B.V. All rights reserved. 2020 Elsevier B.V.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.msard.2020.102324
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2211-0356
EndPage 102324
ExternalDocumentID PMC7311915
32615528
10_1016_j_msard_2020_102324
S2211034820304004
1_s2_0_S2211034820304004
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1P~
1~.
1~5
4.4
457
4G.
53G
5VS
7-5
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABGSF
ABJNI
ABMAC
ABMZM
ABTEW
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGWIK
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
EBS
EFJIC
EFKBS
EFLBG
EJD
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
KOM
M41
MO0
MOBAO
O-L
O9-
OAUVE
OP~
P-8
P-9
PC.
Q38
ROL
SDF
SEL
SPCBC
SSH
SSN
SSU
SSZ
T5K
Z5R
~G-
~HD
AACTN
AFKWA
AJOXV
AMFUW
RIG
AADPK
AAIAV
ABLVK
ABYKQ
AJBFU
DOVZS
LCYCR
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c632t-504bf3f80da57a3f74d3f42a1a8ece15ecf77963b7695a4b82f06cd5e1ab75363
ISICitedReferencesCount 81
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000599869400036&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2211-0348
2211-0356
IngestDate Tue Sep 30 15:36:07 EDT 2025
Sat Sep 27 23:23:27 EDT 2025
Thu Apr 03 07:00:56 EDT 2025
Tue Nov 18 22:33:05 EST 2025
Wed Nov 05 20:46:44 EST 2025
Fri Feb 23 02:45:02 EST 2024
Tue Feb 25 20:07:11 EST 2025
Tue Oct 14 19:31:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Keywords COVID-19
ADEM
NMOSD
Demyelinating event
Language English
License Copyright © 2020 Elsevier B.V. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c632t-504bf3f80da57a3f74d3f42a1a8ece15ecf77963b7695a4b82f06cd5e1ab75363
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1148-3998
0000-0002-3224-8807
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7311915
PMID 32615528
PQID 2420135509
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7311915
proquest_miscellaneous_2420135509
pubmed_primary_32615528
crossref_primary_10_1016_j_msard_2020_102324
crossref_citationtrail_10_1016_j_msard_2020_102324
elsevier_sciencedirect_doi_10_1016_j_msard_2020_102324
elsevier_clinicalkeyesjournals_1_s2_0_S2211034820304004
elsevier_clinicalkey_doi_10_1016_j_msard_2020_102324
PublicationCentury 2000
PublicationDate 2020-09-01
PublicationDateYYYYMMDD 2020-09-01
PublicationDate_xml – month: 09
  year: 2020
  text: 2020-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Multiple sclerosis and related disorders
PublicationTitleAlternate Mult Scler Relat Disord
PublicationYear 2020
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Cheng, Skinner, Lane (bib0004) 2019; 8
Panciani, Saraceno, Zanin, Renisi, Signorini, Battaglia, Fontanella (bib0008) 2020
Savarin, Bergmann (bib0010) 2017; 308
Wingerchuk, Banwell, Bennett, Cabre, Carroll, Chitnis, De Seze, Fujihara, Greenberg, Jacob (bib0012) 2015; 85
Yin, Wang, Tang, Wen, Zhang, Wang (bib0015) 2004; 16
Asadi-Pooya, Simani (bib0001) 2020
Poyiadji, Shahin, Noujaim, Stone, Patel, Griffith (bib0009) 2020
Ashrafi, Azizimalamiri, Badv, Tavasoli, Nikkhah, Montazerlotfelahi, Vafaee-Shahi, Heidari (bib0002) 2020; 30
Kim, Heo, Kim, Song, Park, Park, Ahn, Kim, Choi (bib0006) 2017; 13
Klein, Garber, Howard (bib0007) 2017; 18
Desforges, Le Coupanec, Dubeau, Bourgouin, Lajoie, Dubé, Talbot (bib0005) 2020; 12
Zanin, Saraceno, Panciani, Renisi, Signorini, Migliorati, Fontanella (bib0016) 2020
Wu, Xu, Chen, Duan, Hashimoto, Yang, Liu, Yang (bib0013) 2020
Toscano, Palmerini, Ravaglia, Ruiz, Invernizzi, Cuzzoni, Franciotta, Baldanti, Daturi, Postorino (bib0011) 2020
Bohmwald, Galvez, Ríos, Kalergis (bib0003) 2018; 12
Ye, Ren, Lv (bib0014) 2020
Zhao, Shen, Zhou, Liu, Chen (bib0017) 2020; 19
Wingerchuk (10.1016/j.msard.2020.102324_bib0012) 2015; 85
Wu (10.1016/j.msard.2020.102324_bib0013) 2020
Asadi-Pooya (10.1016/j.msard.2020.102324_bib0001) 2020
Ye (10.1016/j.msard.2020.102324_bib0014) 2020
Kim (10.1016/j.msard.2020.102324_bib0006) 2017; 13
Savarin (10.1016/j.msard.2020.102324_bib0010) 2017; 308
Zhao (10.1016/j.msard.2020.102324_bib0017) 2020; 19
Ashrafi (10.1016/j.msard.2020.102324_bib0002) 2020; 30
Poyiadji (10.1016/j.msard.2020.102324_bib0009) 2020
Klein (10.1016/j.msard.2020.102324_bib0007) 2017; 18
Desforges (10.1016/j.msard.2020.102324_bib0005) 2020; 12
Toscano (10.1016/j.msard.2020.102324_bib0011) 2020
Zanin (10.1016/j.msard.2020.102324_bib0016) 2020
Cheng (10.1016/j.msard.2020.102324_bib0004) 2019; 8
Panciani (10.1016/j.msard.2020.102324_bib0008) 2020
Bohmwald (10.1016/j.msard.2020.102324_bib0003) 2018; 12
Yin (10.1016/j.msard.2020.102324_bib0015) 2004; 16
References_xml – start-page: 1
  year: 2020
  end-page: 4
  ident: bib0016
  article-title: "SARS-CoV-2 can induce brain and spine demyelinating lesions
  publication-title: Acta Neurochir (Wien)
– volume: 19
  start-page: 383
  year: 2020
  end-page: 384
  ident: bib0017
  article-title: "Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
  publication-title: The Lancet Neurology
– volume: 12
  start-page: 14
  year: 2020
  ident: bib0005
  article-title: Human Coronaviruses and Other Respiratory Viruses: underestimated Opportunistic Pathogens of the Central Nervous System?
  publication-title: Viruses
– year: 2020
  ident: bib0013
  article-title: "Nervous system involvement after infection with COVID-19 and other coronaviruses
  publication-title: Brain Behav. Immun.
– volume: 18
  start-page: 132
  year: 2017
  ident: bib0007
  article-title: "Infectious immunity in the central nervous system and brain function
  publication-title: Nat. Immunol.
– year: 2020
  ident: bib0008
  article-title: “SARS-CoV-2:”Three-steps" infection model and CSF diagnostic implication
  publication-title: Brain Behav. Immun.
– volume: 12
  start-page: 386
  year: 2018
  ident: bib0003
  article-title: "Neurologic alterations due to respiratory virus infections
  publication-title: Front Cell Neurosci
– volume: 30
  year: 2020
  ident: bib0002
  article-title: Coronavirus Its Neurologic Manifestations, and Complications."
  publication-title: Iran J Pediatr
– year: 2020
  ident: bib0009
  article-title: COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features
  publication-title: Radiology
– volume: 16
  start-page: 646
  year: 2004
  end-page: 650
  ident: bib0015
  article-title: "Clinical analysis of multiple organ dysfunction syndrome in patients suffering from SARS
  publication-title: Zhongguo wei zhong bing ji jiu yi xue= Chinese critical care medicine= Zhongguo weizhongbing jijiuyixue
– volume: 308
  start-page: 12
  year: 2017
  end-page: 16
  ident: bib0010
  article-title: "Viral-induced suppression of self-reactive T cells: lessons from neurotropic coronavirus-induced demyelination
  publication-title: J. Neuroimmunol.
– volume: 13
  start-page: 227
  year: 2017
  end-page: 233
  ident: bib0006
  article-title: Neurological complications during treatment of Middle East respiratory syndrome
  publication-title: Journal of Clinical Neurology
– volume: 85
  start-page: 177
  year: 2015
  end-page: 189
  ident: bib0012
  article-title: "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
  publication-title: Neurology
– year: 2020
  ident: bib0014
  article-title: "Encephalitis as a clinical manifestation of COVID-19
  publication-title: Brain Behav. Immun.
– year: 2020
  ident: bib0011
  article-title: "Guillain–Barré Syndrome Associated with SARS-CoV-2
  publication-title: New England Journal of Medicine
– volume: 8
  start-page: 3
  year: 2019
  ident: bib0004
  article-title: "Innate immune responses and Viral-Induced neurologic disease
  publication-title: J Clin Med
– year: 2020
  ident: bib0001
  article-title: "Central nervous system manifestations of COVID-19: a systematic review
  publication-title: J. Neurol. Sci.
– volume: 30
  issue: 2
  year: 2020
  ident: 10.1016/j.msard.2020.102324_bib0002
  article-title: Coronavirus Its Neurologic Manifestations, and Complications."
  publication-title: Iran J Pediatr
  doi: 10.5812/ijp.102569
– year: 2020
  ident: 10.1016/j.msard.2020.102324_bib0013
  article-title: "Nervous system involvement after infection with COVID-19 and other coronaviruses
  publication-title: Brain Behav. Immun.
– year: 2020
  ident: 10.1016/j.msard.2020.102324_bib0001
  article-title: "Central nervous system manifestations of COVID-19: a systematic review
  publication-title: J. Neurol. Sci.
  doi: 10.1016/j.jns.2020.116832
– start-page: 1
  year: 2020
  ident: 10.1016/j.msard.2020.102324_bib0016
  article-title: "SARS-CoV-2 can induce brain and spine demyelinating lesions
  publication-title: Acta Neurochir (Wien)
– year: 2020
  ident: 10.1016/j.msard.2020.102324_bib0014
  article-title: "Encephalitis as a clinical manifestation of COVID-19
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2020.04.017
– year: 2020
  ident: 10.1016/j.msard.2020.102324_bib0011
  article-title: "Guillain–Barré Syndrome Associated with SARS-CoV-2
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMc2009191
– volume: 8
  start-page: 3
  issue: 1
  year: 2019
  ident: 10.1016/j.msard.2020.102324_bib0004
  article-title: "Innate immune responses and Viral-Induced neurologic disease
  publication-title: J Clin Med
  doi: 10.3390/jcm8010003
– volume: 19
  start-page: 383
  issue: 5
  year: 2020
  ident: 10.1016/j.msard.2020.102324_bib0017
  article-title: "Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
  publication-title: The Lancet Neurology
  doi: 10.1016/S1474-4422(20)30109-5
– year: 2020
  ident: 10.1016/j.msard.2020.102324_bib0008
  article-title: “SARS-CoV-2:”Three-steps" infection model and CSF diagnostic implication
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2020.05.002
– volume: 85
  start-page: 177
  issue: 2
  year: 2015
  ident: 10.1016/j.msard.2020.102324_bib0012
  article-title: "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000001729
– volume: 13
  start-page: 227
  issue: 3
  year: 2017
  ident: 10.1016/j.msard.2020.102324_bib0006
  article-title: Neurological complications during treatment of Middle East respiratory syndrome
  publication-title: Journal of Clinical Neurology
  doi: 10.3988/jcn.2017.13.3.227
– volume: 12
  start-page: 14
  issue: 1
  year: 2020
  ident: 10.1016/j.msard.2020.102324_bib0005
  article-title: Human Coronaviruses and Other Respiratory Viruses: underestimated Opportunistic Pathogens of the Central Nervous System?
  publication-title: Viruses
  doi: 10.3390/v12010014
– volume: 308
  start-page: 12
  year: 2017
  ident: 10.1016/j.msard.2020.102324_bib0010
  article-title: "Viral-induced suppression of self-reactive T cells: lessons from neurotropic coronavirus-induced demyelination
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2017.01.003
– year: 2020
  ident: 10.1016/j.msard.2020.102324_bib0009
  article-title: COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features
  publication-title: Radiology
  doi: 10.1148/radiol.2020201187
– volume: 18
  start-page: 132
  issue: 2
  year: 2017
  ident: 10.1016/j.msard.2020.102324_bib0007
  article-title: "Infectious immunity in the central nervous system and brain function
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3656
– volume: 16
  start-page: 646
  issue: 11
  year: 2004
  ident: 10.1016/j.msard.2020.102324_bib0015
  article-title: "Clinical analysis of multiple organ dysfunction syndrome in patients suffering from SARS
  publication-title: Zhongguo wei zhong bing ji jiu yi xue= Chinese critical care medicine= Zhongguo weizhongbing jijiuyixue
– volume: 12
  start-page: 386
  year: 2018
  ident: 10.1016/j.msard.2020.102324_bib0003
  article-title: "Neurologic alterations due to respiratory virus infections
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2018.00386
SSID ssj0000651461
Score 2.4741862
Snippet •Clinical awareness of physicians about neurological complications of COVID-19 decreases the mortality rate among infected people.•Neurological presentation of...
Highlights•Clinical awareness of physicians about neurological complications of COVID-19 decreases the mortality rate among infected people. •Neurological...
After the novel coronavirus disease outbreak first began in Wuhan, China, in December 2019, the viral epidemic has quickly spread across the world, and it is...
• Clinical awareness of physicians about neurological complications of COVID-19 decreases the mortality rate among infected people. • Neurological presentation...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 102324
SubjectTerms ADEM
Adult
Case Report
COVID-19
COVID-19 - complications
Demyelinating Diseases - diagnostic imaging
Demyelinating Diseases - virology
Demyelinating event
Encephalomyelitis - diagnostic imaging
Encephalomyelitis - virology
Humans
Lung - diagnostic imaging
Male
Neurology
NMOSD
Young Adult
Title A case of possible atypical demyelinating event of the central nervous system following COVID-19
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2211034820304004
https://www.clinicalkey.es/playcontent/1-s2.0-S2211034820304004
https://dx.doi.org/10.1016/j.msard.2020.102324
https://www.ncbi.nlm.nih.gov/pubmed/32615528
https://www.proquest.com/docview/2420135509
https://pubmed.ncbi.nlm.nih.gov/PMC7311915
Volume 44
WOSCitedRecordID wos000599869400036&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 2211-0356
  dateEnd: 20210531
  omitProxy: false
  ssIdentifier: ssj0000651461
  issn: 2211-0348
  databaseCode: AIEXJ
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6DU17Qdwpl8lIvIVUaW5OHisYokgdCAaqeDFOYqud2rRqQtn6J_jLHN_SlrIBD7xUVWI7ac-Xc8vxdxB6nvmptJvE9eMgcyX_iJvlELXyLhxgYGAYT1SzCXJ6mgyH6ftW64fdC7OckLJMLi7S-X8VNRwDYcuts_8g7mZROADfQejwCWKHz78SfM_JmU7Qz2cS8BPusPpyrl_H8Oml3IDOVLGzIm-yRQKmStMpQXnIslhN8ewIwMnsuyoOePe5_8o1msf2gLLliBXcBNjbsWZ8VhtkwJMtDLVn47d_MU2EJRfKaFw3JuEDm_KV7i7lDNioZtn6RdBslXGV-xnw0aJgxUZuna00nPsTVji9CVuON5MYELHaKi2wQUrZ-b5M1QaaZNxq5jDcUK2SY0Jvt97R-joBcd6ZVvBUdeT6nd3RIKX5VMkcPFZJPJesTWBTmGhP7aEDn0QpqMmDXv9k-LZJ24HHJjuhW_4qVSm4c9kjdGgXusrd2Q1nfq3K3XBzzm6hmyY-wT2Nq9uoxcs76HBgKjDuoq89LOGFZwJbeGELL7wFL6zgJQcCvLC5HDbwwhpeuIEXtvC6hz69Pjl7-cY1XTrcPA782o28MBOBSLyCRYQFgoRFIEKfdVnCc96NeC4IATWfkTiNWJglvvDivIh4l2UQK8fBfbRfzkr-EOGgABOSERGD0QvTXKRhyovQ4xB257EIojby7Z9Jc0NhLzupTKitVTynShhUCoNqYbTRi2bSXDO4XD88tFKidnMymFMKWLt-GvndNF4ZzVDRLq186tGPEumepJSSRQmgt9oobmYar1d7s3--5DMLIgo2Qb7oYyUHEVJwuyGyiyAWaKMHGlTNT7fAhBveglszQPLNb58pxyPFO08CyQYZPbpyzcfoaP1wP0H79eIbf4pu5Mt6XC2O0R4ZJsfmgfoJ5qXxVQ
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+case+of+possible+atypical+demyelinating+event+of+the+central+nervous+system+following+COVID-19&rft.jtitle=Multiple+sclerosis+and+related+disorders&rft.au=Zoghi%2C+Anahita&rft.au=Ramezani%2C+Mahtab&rft.au=Roozbeh%2C+Mehrdad&rft.au=Darazam%2C+Ilad+Alavi&rft.date=2020-09-01&rft.eissn=2211-0356&rft.volume=44&rft.spage=102324&rft_id=info:doi/10.1016%2Fj.msard.2020.102324&rft_id=info%3Apmid%2F32615528&rft.externalDocID=32615528
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F22110348%2FS2211034820X0006X%2Fcov150h.gif